» Articles » PMID: 19816926

Brainstem 1H Nuclear Magnetic Resonance (NMR) Spectroscopy: Marker of Demyelination and Repair in Spinal Cord

Overview
Journal Ann Neurol
Specialty Neurology
Date 2009 Oct 10
PMID 19816926
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Measuring in vivo spinal cord injury and repair remains elusive. Using magnetic resonance spectroscopy (MRS) we examined brainstem N-acetyl-aspartate (NAA) as a surrogate for spinal cord injury in two mouse strains with different reparative phenotypes following virus-induced demyelination. Swiss Jim Lambert (SJL) and Friend Virus B (FVB) mice progressively demyelinate with axonal loss. FVB mice demyelinate similarly but eventually remyelinate coincident with functional recovery. Brainstem NAA levels drop in both but recover in FVB mice. Chronically infected SJL mice lost 30.5% of spinal cord axons compared to FVB mice (7.3%). In remyelination-enhancing or axon-preserving clinical trials, brainstem MRS may be a viable endpoint to represent overall spinal cord dysfunction.

Citing Articles

Multiparametric magnetic resonance imaging for detection of pathological changes in the central nervous system of a mouse model of multiple sclerosis in vivo.

Althobity A, Khan N, Sandrock C, Woodruff T, Cowin G, Brereton I NMR Biomed. 2023; 36(10):e4964.

PMID: 37122101 PMC: 10909458. DOI: 10.1002/nbm.4964.


A monoclonal natural human IgM protects axons in the absence of remyelination.

Wootla B, Denic A, Warrington A, Rodriguez M J Neuroinflammation. 2016; 13(1):94.

PMID: 27126523 PMC: 4850699. DOI: 10.1186/s12974-016-0561-3.


Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease.

Wootla B, Denic A, Watzlawik J, Warrington A, Rodriguez M Mol Neurobiol. 2015; 53(8):5217-28.

PMID: 26409478 PMC: 5012151. DOI: 10.1007/s12035-015-9436-3.


A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis.

Wootla B, Denic A, Watzlawik J, Warrington A, Rodriguez M J Neuroinflammation. 2015; 12:83.

PMID: 25924771 PMC: 4418041. DOI: 10.1186/s12974-015-0303-y.


Correlation of Brain Atrophy, Disability, and Spinal Cord Atrophy in a Murine Model of Multiple Sclerosis.

Paz Soldan M, Raman M, Gamez J, Lohrey A, Chen Y, Pirko I J Neuroimaging. 2015; 25(4):595-9.

PMID: 25893491 PMC: 4506196. DOI: 10.1111/jon.12250.


References
1.
Bieber A, Ure D, Rodriguez M . Genetically dominant spinal cord repair in a murine model of chronic progressive multiple sclerosis. J Neuropathol Exp Neurol. 2005; 64(1):46-57. DOI: 10.1093/jnen/64.1.46. View

2.
Filippi M, Tortorella C, Bozzali M . Normal-appearing white matter changes in multiple sclerosis: the contribution of magnetic resonance techniques. Mult Scler. 1999; 5(4):273-82. DOI: 10.1177/135245859900500414. View

3.
Pirko I, Johnson A, Gamez J, Macura S, Rodriguez M . Disappearing "T1 black holes" in an animal model of multiple sclerosis. Front Biosci. 2004; 9:1222-7. DOI: 10.2741/1322. View

4.
Rooney W, Goodkin D, Schuff N, Meyerhoff D, Norman D, Weiner M . 1H MRSI of normal appearing white matter in multiple sclerosis. Mult Scler. 1997; 3(4):231-7. DOI: 10.1177/135245859700300403. View

5.
Roser W, Hagberg G, Mader I, BRUNNSCHWEILER H, Radue E, Seelig J . Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matter. Magn Reson Med. 1995; 33(6):811-7. DOI: 10.1002/mrm.1910330611. View